Incorrect username and/or password, please try again or click to reset.

Class 2 Medicines recall: Emerade 150, 300 and 500 microgram solution for injection in pre-filled syringe (EL(19)A/39)

2019-11-28 14:14:58 (5 year(s) ago)

Summary

Pharmaswiss ÄŒeska republika s.r.o. (an affiliate of Bausch & Lomb UK Limited) is recalling all unexpired batches of Emerede Adrenaline Autoinjectors after identifying an error than can cause some pens to fail to activate.

Read full MHRA article

Respond to this alert